New Zealand Pharmaceuticals Ltd (NZP) manufactures biochemicals for global supply to the biotechnology, pharmaceutical and health food industries. Most of the company's products are extracted and purified from natural raw materials. Products include bile acids; including cholic acid, deoxycholic acid, their tauro- and glyco- derivatives, glycosaminoglycans, proteins, protease, protein hydrolysates, amino acids, a range of plant-derived products, marine polysaccharides and inositols. NZP specializes in the chemical synthesis of a range of specialty monosaccharides and glycotherapeutic compounds, including the mannosamines, iminosugars and other derivatives. It is expanding into carbohydrate derivatives manufactured initially to pharmaceutical intermediate (API starting materials) and API cGMP when requested. The synthetic bile acid derivatives are used in drug delivery, as adjuvants and in vaccine production amongst other uses. Excellent business relationships, proven to be reliable and responsive are the key to NZP's success as it delivers products on time and in specification.Relationships-NZP is not a catalogue supplier-Works closely with customers, at all times-Both technical and commercial (product development, QC and regulatory; including registration support with DMFs, etc)responsiveness?Prompt response?Documentation complete and correct?Efficient world-wide distribution?Free samples, individual pack sizingReliability?Deliver the right product, on time, in specification NZP has a range of large volume manufacturing capabilities; including extraction, chemical synthesis and crystallisation vessels, ion-exchange, ultra-filtration, spray, tray and rotary drying and solvent recycling capabilities.NZP's licences include a medicines licence for the manufacture of specific medicines, biological processing licence for the manufacture of animal-derived products and a GMP certified to manufacture active pharmaceutical ingredients. The Company is staffed by over 100 trained personnel and is ranked in New Zealand?s Top 500 companies and exports over 99% of its products. The Company fosters innovation throughout its operations and places a high importance on new product development.With the recent completion of a new GMP-compliant manufacturing facility, NZP is now able to offer Contract Manufacturing of a range of synthetic pharmaceutical intermediates and active pharmaceutical ingredients (APIs). Please contact NZP for further information.